219 related articles for article (PubMed ID: 15199888)
1. A consumer's guide to impotence drugs.
Burnett AL
Johns Hopkins Med Lett Health After 50; 2004 Jun; 17(4):6. PubMed ID: 15199888
[No Abstract] [Full Text] [Related]
2. [Erectile dysfunction (ED) and diabetes mellitus].
Takahashi Y
Nihon Rinsho; 2005 Jun; 63 Suppl 6():553-7. PubMed ID: 15999768
[No Abstract] [Full Text] [Related]
3. Visual loss with erectile dysfunction medications.
Wooltorton E
CMAJ; 2006 Aug; 175(4):355. PubMed ID: 16870715
[No Abstract] [Full Text] [Related]
4. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
Shabsigh R; Seftel AD; Rosen RC; Porst H; Ahuja S; Deeley MC; Garcia CS; Giuliano F
Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
[No Abstract] [Full Text] [Related]
5. A pill for impotence.
Utiger RD
N Engl J Med; 1998 May; 338(20):1458-9. PubMed ID: 9580654
[No Abstract] [Full Text] [Related]
6. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.
Agarwal P; Sander GE; Giles TD
Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074
[No Abstract] [Full Text] [Related]
7. Oral drug treatment of erectile dysfunction.
Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
[No Abstract] [Full Text] [Related]
8. Treatment of erectile dysfunction.
Dinsmore W
Int J STD AIDS; 2004 Apr; 15(4):215-21. PubMed ID: 15075013
[TBL] [Abstract][Full Text] [Related]
9. Random musing about a little blue pill.
Finkbeiner A
J Ark Med Soc; 1998 Aug; 95(3):100-1. PubMed ID: 9735630
[No Abstract] [Full Text] [Related]
10. Ophthalmic aspects of erectile dysfunction drugs.
Verit A; Oguz H
Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529
[No Abstract] [Full Text] [Related]
11. [Pharmacotherapy of erectile dysfunction].
Shcheplev PA; Nesterov SN; Kukharkin SA; Abdullaev IA; Sidorov DV
Ter Arkh; 1999; 71(10):76-8. PubMed ID: 10612182
[No Abstract] [Full Text] [Related]
12. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Ghofrani HA; Grimminger F
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
[TBL] [Abstract][Full Text] [Related]
13. Use of Viagra by patients with heart disease.
Holdright D
Hosp Med; 2000 Aug; 61(8):584. PubMed ID: 11045234
[No Abstract] [Full Text] [Related]
14. [Impotence: at last there is hope].
Servir; 1997; 45(3):162. PubMed ID: 9248498
[No Abstract] [Full Text] [Related]
15. PDE-5 inhibitors: current status and future trends.
Masson P; Lambert SM; Brown M; Shabsigh R
Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
[TBL] [Abstract][Full Text] [Related]
16. [Sildenafil].
Sperling H; Michel MC
Dtsch Med Wochenschr; 1999 Feb; 124(6):151-3. PubMed ID: 10081479
[No Abstract] [Full Text] [Related]
17. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.
Dunn ME; Althof SE; Perelman MA
Int J Impot Res; 2007; 19(2):119-23. PubMed ID: 16738695
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction.
Harv Mens Health Watch; 2006 Aug; 11(1):3-4. PubMed ID: 17128442
[No Abstract] [Full Text] [Related]
19. [Treatment of erectile dysfunction].
Romics I
Orv Hetil; 2004 Feb; 145(9):491-3. PubMed ID: 15077482
[No Abstract] [Full Text] [Related]
20. Sildenafil: a revolutionary therapy?
Marshall SM
Diabet Med; 1998 Nov; 15(11):897-9. PubMed ID: 9827843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
